- Home
- IMRN vs SBFM Comparison
IMRN vs SBFM Comparison
Compare IMRN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SBFM
- Stock Information
- Founded
- IMRN 1994
- SBFM 2006
- Country
- IMRN Australia
- SBFM United States
- Employees
- IMRN N/A
- SBFM N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- SBFM Health Care
- Exchange
- IMRN Nasdaq
- SBFM Nasdaq
- Market Cap
- IMRN 9.2M
- SBFM 7.7M
- IPO Year
- IMRN N/A
- SBFM N/A
- Fundamental
- Price
- IMRN $1.74
- SBFM $1.45
- Analyst Decision
- IMRN Strong Buy
- SBFM Strong Buy
- Analyst Count
- IMRN 1
- SBFM 1
- Target Price
- IMRN $5.00
- SBFM $15.00
- AVG Volume (30 Days)
- IMRN 24.7K
- SBFM 84.3K
- Earning Date
- IMRN 07-07-2025
- SBFM 08-15-2025
- Dividend Yield
- IMRN N/A
- SBFM N/A
- EPS Growth
- IMRN N/A
- SBFM N/A
- EPS
- IMRN N/A
- SBFM N/A
- Revenue
- IMRN $4,048,286.00
- SBFM $36,234,578.00
- Revenue This Year
- IMRN N/A
- SBFM $192.48
- Revenue Next Year
- IMRN N/A
- SBFM N/A
- P/E Ratio
- IMRN N/A
- SBFM N/A
- Revenue Growth
- IMRN 82.90
- SBFM 35.51
- 52 Week Low
- IMRN $1.50
- SBFM $1.17
- 52 Week High
- IMRN $2.87
- SBFM $8.78
- Technical
- Relative Strength Index (RSI)
- IMRN 58.70
- SBFM 48.48
- Support Level
- IMRN $1.68
- SBFM $1.41
- Resistance Level
- IMRN $1.94
- SBFM $1.58
- Average True Range (ATR)
- IMRN 0.09
- SBFM 0.12
- MACD
- IMRN 0.02
- SBFM -0.01
- Stochastic Oscillator
- IMRN 76.92
- SBFM 18.91
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.